BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31859225)

  • 1. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
    Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
    Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
    Murugappan MN; Seifert RD; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
    Hung A; Wilson L; Smith VA; Pavon JM; Sloan CE; Hastings SN; Farley J; Maciejewski ML
    JAMA Health Forum; 2024 May; 5(5):e240807. PubMed ID: 38700854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
    Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
    Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
    Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
    Allen A; Hung A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
    Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.
    Chou J; Pellegrin K; Cooke CE; Zarowitz B; Hanlon A; Lozano A; Brandt NJ
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1276-1281. PubMed ID: 32996388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare Medication Therapy Management: beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013-2016).
    Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC
    J Am Pharm Assoc (2003); 2024 May; ():102140. PubMed ID: 38825153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
    Miller DE; Roane TE; Salo JA; Hardin HC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.
    Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME
    J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of comprehensive medication reviews on potentially inappropriate medication discontinuation in Medicare beneficiaries.
    Hung A; Wilson LE; Smith VA; Pavon JM; Sloan CE; Hastings SN; Maciejewski ML
    J Am Geriatr Soc; 2024 Jun; ():. PubMed ID: 38826070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social determinants predict whether Medicare beneficiaries are offered a Comprehensive Medication Review.
    Lee M; Zarowitz BJ; Pellegrin K; Cooke CE; Fleming SP; Brandt N
    Res Social Adm Pharm; 2023 Jan; 19(1):184-188. PubMed ID: 36216754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.
    Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC
    Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
    Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.